Product Name:Isoquinoline, 4-(3-bromophenyl)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-, (4S)-

IUPAC Name:(4S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline

CAS:1870821-29-6
Molecular Formula:C16H14BrCl2N
Purity:95%+
Catalog Number:CM429816
Molecular Weight:371.1

Packing Unit Available Stock Price($) Quantity
CM429816-100mg in stock NJĽư
CM429816-250mg in stock Ľʼnź
CM429816-1g in stock ưNJư

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1870821-29-6
Molecular Formula:C16H14BrCl2N
Melting Point:-
Smiles Code:CN1C[C@@H](C2=CC(Br)=CC=C2)C2=C(C1)C(Cl)=CC(Cl)=C2
Density:
Catalog Number:CM429816
Molecular Weight:371.1
Boiling Point:
MDL No:MFCD27939616
Storage:

Category Infos

Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.

Column Infos

Tenapanor
FDA has approved XPHOZAH (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

XPHOZAH, with its unique blocking mechanism of action, acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3), reducing phosphate absorption through the paracellular pathway, the primary pathway of phosphate absorption.